|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
In line with the Board of Directors decision dated 11.07.2023 Dr. Nadir ULU who serves as Assistant General Manager Responsible from R&D and production appointed as Assistant General Manager responsible from R&D and Clinical Operations. Technical Operations Directorate is formed and Mustafa Gürcan ÜSGÜLEN who serves as Quality Director in our company appointed as Technical Operations Director. Technical Maintanence, Projects, Production Planning, Sterile Production, Non-Sterile Production, Sterile Packaging and Warehouse departments are organized under this directorate. Halil GÜNERİ is appointed to the vacant Quality Director position. With this subjected decision support of our company's growth and corporate development, acceleration of innovative R&D studies and product research are aimed.
|
||||||||